Complementary Integrative Rehabilitation Medicine

Pediatric Rehabilitation

Clinical Practice (assessment, diagnosis, treatment, knowledge translation/EBP, implementation science, program development)

Special Symposium

(577202) SPECIAL SYMPOSIUM: What is the Evidence for Neurofeedback for Attention-deficit/hyperactivity Disorder?

Presenter(s)

• 

  L. Eugene Arnold, MEd, MD

  Professor Emeritus of Psychiatry & Behavioral Health
  Ohio State University
  Columbus, Ohio

Treatments with long-term benefit for attention-deficit/hyperactivity disorder (ADHD) are needed; one of the more promising is Neurofeedback (EEG Biofeedback), which has several Randomized controlled trials showing significant benefit, but which are inconclusive because they were not Double-Blinded; the benefit could have been nonspecific (placebo response). Because of Neurofeedback's labor-intensive cost, it is important to know how much specific benefit it yields. This presentation will review and critique the evidence base for neurofeedback (EEG biofeedback (NF) as treatment for ADHD and unveil preliminary results of an NIMH-funded double-blind 2-site randomized clinical trial (RCT) designed to address flaws of previous studies.

Learning Objectives:

• Understand how neurofeedback training can modify abnormal EEG waves to theoretically improve individuals’ cognitive and behavioral performance
• Discuss meta-analysis of published randomized controlled trials (RCTs) of neurofeedback for attention-deficit/hyperactivity disorder (ADHD)
• Understand flaws in published research on neurofeedback for ADHD.
• Understand the preliminary outcomes and follow-up of the most recent RCT of neurofeedback for ADHD.
• Evaluate the effectiveness and safety of neurofeedback on attention deficit hyperactivity disorder